• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在小鼠L细胞中表达的原癌基因ret产物的特性分析。

Characterization of the ret proto-oncogene products expressed in mouse L cells.

作者信息

Takahashi M, Asai N, Iwashita T, Isomura T, Miyazaki K, Matsuyama M

机构信息

Department of Pathology, Nagoya University School of Medicine, Japan.

出版信息

Oncogene. 1993 Nov;8(11):2925-9.

PMID:8414495
Abstract

The ret proto-oncogene (proto-ret) encodes a receptor type tyrosine kinase with a cadherin-related sequence in the extracellular domain. To investigate whether the proto-Ret protein functions as a cell adhesion molecule like cadherins, we transfected the human proto-ret gene fused to the SV40 promoter or cytomegalovirus (CMV) promoter into mouse L cells in which cadherins are not expressed. Three transfectants with high levels of expression of the proto-Ret proteins were obtained. The proto-Ret proteins were expressed as 150 kDa and 170 kDa glycoproteins in transfectants as observed in human neuroblastoma cells. Cell fractionation experiments revealed that the 170 kDa protein but not the 150 kDa protein was detected predominantly in the plasma membrane fraction, indicating that the 170 kDa protein represents the mature glycosylated form of the proto-Ret protein present on the cell surface. Both 150 kDa and 170 kDa proto-Ret proteins showed tyrosine kinase activity in immunocomplex kinase assay. It is known that cadherins have Ca(2+)-dependent homophilic binding activity and are resistant to trypsinization in the presence of Ca2+. When L cells expressing the proto-Ret proteins were treated with trypsin in the presence of Ca2+, the 170 kDa protein was resistant to its digestion. On the other hand, it was completely digested in the presence of EGTA, suggesting the possibility that the proto-Ret protein interacts with Ca2+ like cadherins. However, the transfectants did not show clear adhesive properties in cell aggregation assays.

摘要

原癌基因ret(proto-ret)编码一种受体型酪氨酸激酶,其胞外结构域含有一个与钙黏蛋白相关的序列。为了研究原Ret蛋白是否像钙黏蛋白一样作为细胞黏附分子发挥作用,我们将与SV40启动子或巨细胞病毒(CMV)启动子融合的人原ret基因转染到不表达钙黏蛋白的小鼠L细胞中。获得了三个原Ret蛋白高表达的转染细胞株。在转染细胞中,原Ret蛋白表达为150 kDa和170 kDa的糖蛋白,这与在人神经母细胞瘤细胞中观察到的情况一致。细胞分级分离实验表明,170 kDa的蛋白而非150 kDa的蛋白主要在质膜组分中被检测到,这表明170 kDa的蛋白代表细胞表面存在的原Ret蛋白的成熟糖基化形式。在免疫复合物激酶测定中,150 kDa和170 kDa的原Ret蛋白均显示出酪氨酸激酶活性。已知钙黏蛋白具有Ca(2+)依赖的同源性结合活性,并且在有Ca2+存在时对胰蛋白酶消化具有抗性。当在有Ca2+存在的情况下用胰蛋白酶处理表达原Ret蛋白的L细胞时,170 kDa的蛋白对其消化具有抗性。另一方面,在有乙二醇双四乙酸(EGTA)存在时它被完全消化,这提示原Ret蛋白可能像钙黏蛋白一样与Ca2+相互作用。然而,在细胞聚集试验中转染细胞并未表现出明显的黏附特性。

相似文献

1
Characterization of the ret proto-oncogene products expressed in mouse L cells.在小鼠L细胞中表达的原癌基因ret产物的特性分析。
Oncogene. 1993 Nov;8(11):2925-9.
2
Tyrosine kinase activity of the ret proto-oncogene products in vitro.
Biochem Biophys Res Commun. 1993 Jun 15;193(2):565-70. doi: 10.1006/bbrc.1993.1661.
3
cDNA cloning of mouse ret proto-oncogene and its sequence similarity to the cadherin superfamily.小鼠原癌基因ret的cDNA克隆及其与钙黏蛋白超家族的序列相似性。
Oncogene. 1993 Apr;8(4):1087-91.
4
Mechanism of activation of the ret proto-oncogene by multiple endocrine neoplasia 2A mutations.多发性内分泌腺瘤病2A突变激活ret原癌基因的机制。
Mol Cell Biol. 1995 Mar;15(3):1613-9. doi: 10.1128/MCB.15.3.1613.
5
Molecular modeling of the extracellular domain of the RET receptor tyrosine kinase reveals multiple cadherin-like domains and a calcium-binding site.RET受体酪氨酸激酶胞外域的分子建模揭示了多个钙黏蛋白样结构域和一个钙结合位点。
J Biol Chem. 2001 Sep 21;276(38):35808-17. doi: 10.1074/jbc.M104968200. Epub 2001 Jul 9.
6
Identification of the product of two oncogenic rearranged forms of the RET proto-oncogene in papillary thyroid carcinomas.在甲状腺乳头状癌中鉴定RET原癌基因两种致癌重排形式的产物。
Oncogene. 1992 Nov;7(11):2189-94.
7
Ret-mediated mitogenesis requires Src kinase activity.
Cancer Res. 1999 Mar 1;59(5):1120-6.
8
Grb2 binding to the different isoforms of Ret tyrosine kinase.生长因子受体结合蛋白2(Grb2)与Ret酪氨酸激酶的不同异构体结合。
Oncogene. 1998 Sep 3;17(9):1079-87. doi: 10.1038/sj.onc.1202046.
9
Motifs of cadherin- and fibronectin type III-related sequences and evolution of the receptor-type-protein tyrosine kinases: sequence similarity between proto-oncogene ret and cadherin family.钙黏蛋白和纤连蛋白III型相关序列基序与受体型蛋白酪氨酸激酶的进化:原癌基因ret与钙黏蛋白家族之间的序列相似性
Mol Biol Evol. 1993 May;10(3):539-51. doi: 10.1093/oxfordjournals.molbev.a040033.
10
Molecular characterization of RET/PTC3; a novel rearranged version of the RETproto-oncogene in a human thyroid papillary carcinoma.RET/PTC3的分子特征;人类甲状腺乳头状癌中RET原癌基因的一种新的重排形式
Oncogene. 1994 Feb;9(2):509-16.

引用本文的文献

1
Molecular Basis and Natural History of Medullary Thyroid Cancer: It is (Almost) All in the .甲状腺髓样癌的分子基础与自然史:(几乎)都与……有关 。 (你提供的原文最后不完整,所以译文也只能到这个程度)
Cancers (Basel). 2023 Oct 5;15(19):4865. doi: 10.3390/cancers15194865.
2
RET kinase inhibitors for -altered thyroid cancers.用于RET基因改变的甲状腺癌的RET激酶抑制剂。
Ther Adv Med Oncol. 2022 Jun 21;14:17588359221101691. doi: 10.1177/17588359221101691. eCollection 2022.
3
RET Receptor Tyrosine Kinase: Role in Neurodegeneration, Obesity, and Cancer.
RET 受体酪氨酸激酶:在神经退行性变、肥胖和癌症中的作用。
Int J Mol Sci. 2020 Sep 26;21(19):7108. doi: 10.3390/ijms21197108.
4
RET Functions as a Dual-Specificity Kinase that Requires Allosteric Inputs from Juxtamembrane Elements.RET作为一种双特异性激酶发挥作用,需要来自近膜元件的变构输入。
Cell Rep. 2016 Dec 20;17(12):3319-3332. doi: 10.1016/j.celrep.2016.11.061.
5
MEN 2A-related cutaneous lichen amyloidosis: report of three kindred and systematic literature review of clinical, biochemical and molecular characteristics.与2A型多发性内分泌腺瘤相关的皮肤苔藓样淀粉样变:三个家系报告及临床、生化和分子特征的系统文献综述
Fam Cancer. 2016 Oct;15(4):625-33. doi: 10.1007/s10689-016-9892-6.
6
A comprehensive overview of the role of the RET proto-oncogene in thyroid carcinoma.RET 原癌基因在甲状腺癌中的作用的全面概述。
Nat Rev Endocrinol. 2016 Apr;12(4):192-202. doi: 10.1038/nrendo.2016.11. Epub 2016 Feb 12.
7
Thyroid Cancer: Role of RET and Beyond.甲状腺癌:RET及其他因素的作用
Eur Thyroid J. 2012 Apr;1(1):15-23. doi: 10.1159/000336975. Epub 2012 Mar 28.
8
Enigma prevents Cbl-c-mediated ubiquitination and degradation of RETMEN2A.谜蛋白可阻止Cbl-c介导的RETMEN2A泛素化及降解。
PLoS One. 2014 Jan 23;9(1):e87116. doi: 10.1371/journal.pone.0087116. eCollection 2014.
9
Central role of RET in thyroid cancer.REET 在甲状腺癌中的核心作用。
Cold Spring Harb Perspect Biol. 2013 Dec 1;5(12):a009233. doi: 10.1101/cshperspect.a009233.
10
Advanced medullary thyroid cancer: pathophysiology and management.高级甲状腺髓样癌:病理生理学与治疗。
Cancer Manag Res. 2013 May 8;5:57-66. doi: 10.2147/CMAR.S33105. Print 2013.